Altria reported some declines in the first quarter of 2025, but its oral tobacco products segment maintained momentum in a competitive marketplace.
During the presentation of its first-quarter results, Altria said the oral tobacco products segment reported domestic shipment volume down by 5%, primarily driven by retail share losses, calendar differences, trade inventory movements and other factors, partially offset by the industry’s growth rate.
